Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
12/2002
12/05/2002CA2411082A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
12/04/2002EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
11/2002
11/28/2002US20020176861 A phosphate derivative when co-administered with antigens such as vaccines for bacterial and viral diseases function as immunological adjuvant
11/28/2002DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/27/2002EP1260498A1 Novel color former and recording material
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002CN1381442A Process for preparing biurea
11/27/2002CN1094943C Urethanes and ureas that induce cytokine production
11/26/2002US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002US6486178 Indane derivatives
11/21/2002WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/20/2002CN1380285A Novel compound, its preparation method and application as colouring matter and cosmetic composition
11/20/2002CN1094488C Polymerizable urea/ureido functional monomers
11/19/2002US6482849 Inhibitors of α4β1 mediated cell adhesion
11/14/2002WO2002090336A1 Substituted arylketones
11/14/2002WO2002038534A3 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
11/14/2002US20020169217 Urea derivatives as hyrophobic particles obtained by crystallization from a clear homogeneous melt dispersed in a carrier; printing inks; cooling lubricants;
11/14/2002US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002CA2449187A1 Substituted arylketones
11/13/2002EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002EP0877731B1 Aqueous emuslions comprising fluorocarbon-containing isocyanate derivatives as soil-resist agents
11/12/2002US6479587 Crosslinkable polyurea polymers
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002US6479485 Benzamidine derivatives and their use as anti-coagulants
11/12/2002US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/07/2002US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002US20020165282 PPAR agonists
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/05/2002US6476262 Reacting ammonia and carbon dioxide
11/05/2002US6476224 N-(4-cyano-2,5- difluoro-phenyl) -3-(dimethylaminocarbonylamino)-4,4,4-trifluoro-2-butenamide and 1,2-dimethoxyethane are heated to form ar(alk)yl uracil compound
11/05/2002US6476202 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol compounds and method of using them
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476056 Antiinflammatory agents, psychological disorders
11/05/2002US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085836A1 Binaphtol derivative and process for producing the same
10/31/2002WO2002085829A1 Process for production of dimers of aromatic monohydroxyl compounds
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001058855A9 Use of androgen receptor suppressors
10/31/2002US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002US20020161225 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative
10/31/2002US20020161040 N-ethyloxycarbonyl-4-aminophenol for example, in depigmentation of skin, hair
10/30/2002EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002EP1252136A1 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof
10/30/2002EP1252135A2 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
10/30/2002EP1004573B1 Aryloxyaniline derivatives
10/30/2002CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/29/2002US6472529 Viricides
10/29/2002US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/24/2002WO2002083627A2 Ligands des integrins avss6
10/24/2002US20020156212 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
10/24/2002CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/23/2002EP1251121A1 Anthraquinone derivatives, process for their preparation and use as pigments and cosmetic compositions
10/23/2002EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002EP1250315A1 Functional monomers for molecular recognition and catalysis
10/23/2002CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/22/2002US6468406 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
10/17/2002US20020151586 Antidiabetic agents
10/17/2002DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/16/2002EP0920434B1 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
10/16/2002EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002CN1374295A Prepn of biurea
10/16/2002CN1374294A Polyisocyanate containing acyl urea group, its producing process and its application
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465459 Inhibit the enzyme, factor xa
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002078686A1 Retinyl carbonates in cosmetic and dermatological preparations
10/10/2002WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002US20020147365 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002US20020147182 13-substituted methacycline compounds
10/10/2002DE10116768A1 Hypoglycemic medicaments useful for treating type II diabetes contain new or known N-aroyl-N'-phenyl-urea derivatives which are glycogen phosphorylase a inhibitors
10/10/2002DE10115840A1 Retinylcarbonate in Kosmetika und Dermatika Retinylcarbonate in cosmetics and skin
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP0819106B1 Process for preparing granular urea
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 99